MedPath

A study to assess acute toxicities in lung carcinoma patients treated with curative intent of radiotherapy with modern radiotherapy technique

Not Applicable
Conditions
Health Condition 1: C34- Malignant neoplasm of bronchus andlung
Registration Number
CTRI/2024/04/066252
Lead Sponsor
Dr. Flavia Lyn Jashan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed with histologically confirmed lung carcinoma.

2.Patients scheduled for radiotherapy with a radical intent using the VMAT technique.

3.Age 18 years or older.

4.Adequate baseline pulmonary function tests for safe participation

Exclusion Criteria

Lung cancer patients treated with palliative radiotherapy.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath